AlerisLife Inc. (ALR) NASDAQ
$0.69 0.04 (6.15%)
Market Cap: $21.20M
As of 01/27/23 04:30 PM EST. Market closed.
AlerisLife Inc. (ALR) NASDAQ
$0.69 0.04 (6.15%)
Market Cap: $21.20M
As of 01/27/23 04:30 PM EST. Market closed.
Five Star Senior Living (FVE) is a senior living and rehabilitation and wellness services company. As of Sept. 30, 2020, FVE operated 263 senior living communities (30,544 living units) located in 31 states, including 239 communities (28,232 living units) that it managed and 24 communities (2,312 living units) that it owned or leased. FVE operates communities that include independent living, ... read more
Five Star Senior Living (FVE) is a senior living and rehabilitation and wellness services company. As of Sept. 30, 2020, FVE operated 263 senior living communities (30,544 living units) located in 31 states, including 239 communities (28,232 living units) that it managed and 24 communities (2,312 living units) that it owned or leased. FVE operates communities that include independent living, assisted living, continuing care retirement and skilled nursing communities. Additionally, FVE's rehabilitation and wellness services segment includes Ageility Physical Therapy SolutionsTM, or Ageility, a division of FVE, which provides rehabilitation and wellness services within FVE communities as well as to external customers. As of Sept. 30, 2020, Ageility operated 209 outpatient rehabilitation clinics and 40 inpatient rehabilitation clinics. FVE is headquartered in Newton, Massachusetts. read less
COMPANY PROFILE
Sector
Health Care and Social Assistance
Industry
General Medical and Surgical Hospitals
Sector
Health Care and Social Assistance
Industry
General Medical and Surgical Hospitals
Full Time Employees
10,400
Address
.
PRICE CHART
From:
To:
NEWS
KEY STATS
Open
$0.68
Previous Close
$0.65
Days Range
$0.63 - $0.70
52 week range
$0.55 - $3.04
Volume
159,015
Avg. Volume (30 days)
198,047
Market Cap
$21.20M
Dividend Yield
0.00%
P/E
-0.56
Shares Outstanding
32,609,007
Open
$0.68
Previous Close
$0.65
Days Range
$0.63 - $0.70
52 week range
$0.55 - $3.04
Volume
159,015
Avg. Volume (30 days)
198,047
Market Cap
$21.20M
Dividend Yield
0.00%
P/E
-0.56
Shares Outstanding
32,609,007
Open in:
Open in:
INSIDER TRANSACTIONS FOR ALERISLIFE INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Cramp Daniella | Global Pres., Cardiometabolic | Aug 31, 2017 | Option Exercise | $49.46 | 12,254 | 606,083 | 28,298 | Sep 05, 2017, 07:51 PM |
| Cramp Daniella | Global Pres., Cardiometabolic | Aug 31, 2017 | Option Exercise | $48.14 | 10,000 | 481,400 | 36,355 | Sep 05, 2017, 07:51 PM |
| BRIDGEN JOHN | Sr VP, Business Develop | Aug 31, 2017 | Option Exercise | $49.46 | 1,879 | 92,935 | 20,646 | Sep 05, 2017, 07:43 PM |
| Chiniara Ellen | GC, Chief Ethics Officer&Sec | Aug 31, 2017 | Option Exercise | $49.46 | 2,163 | 106,982 | 32,764 | Sep 05, 2017, 07:43 PM |
| Gladwell Mark | Senior VP, Global Operations | Aug 31, 2017 | Option Exercise | $49.46 | 2,350 | 116,231 | 9,791 | Sep 05, 2017, 07:42 PM |
| Guerdan Melissa | SVP, Global Quality & Reg. | Aug 31, 2017 | Option Exercise | $49.46 | 3,131 | 154,859 | 16,385 | Sep 05, 2017, 07:41 PM |
| Hargadon Robert Bernard | SVP, Global Human Resources | Aug 31, 2017 | Option Exercise | $49.46 | 1,823 | 90,166 | 26,190 | Sep 05, 2017, 07:40 PM |
| Malkani Sanjay | Global Pres., Toxicology | Aug 31, 2017 | Option Exercise | $49.46 | 2,038 | 100,799 | 28,757 | Sep 05, 2017, 07:32 PM |
| Pelossof Avi | GlobalPres, Infectious Disease | Aug 31, 2017 | Option Exercise | $49.46 | 2,464 | 121,869 | 26,005 | Sep 05, 2017, 07:31 PM |
| Nawana Namal | Chief Executive Officer | Jan 15, 2017 | Option Exercise | $39.89 | 23,525 | 938,412 | 145,517 | Jun 16, 2017, 06:50 PM |
| Uppaluri Renuka | Senior VP, Global R&D | Feb 28, 2017 | Option Exercise | $38.30 | 2,505 | 95,941 | 13,267 | Mar 02, 2017, 06:08 PM |
| Uppaluri Renuka | Senior VP, Global R&D | Feb 16, 2017 | Option Exercise | $40.40 | 3,169 | 128,028 | 9,105 | Feb 21, 2017, 06:25 PM |
| Pelossof Avi | GlobalPres, Infectious Disease | Feb 16, 2017 | Option Exercise | $40.40 | 3,665 | 148,066 | 21,802 | Feb 21, 2017, 06:22 PM |
| Nawana Namal | Chief Executive Officer | Feb 16, 2017 | Option Exercise | $40.40 | 18,576 | 750,470 | 147,654 | Feb 21, 2017, 06:21 PM |
| Malkani Sanjay | Global Pres., Toxicology | Feb 16, 2017 | Option Exercise | $40.40 | 3,027 | 122,291 | 24,128 | Feb 21, 2017, 06:19 PM |
| Hinrichs James F. | Executive VP, CFO | Feb 16, 2017 | Option Exercise | $40.40 | 5,260 | 212,504 | 55,563 | Feb 21, 2017, 06:18 PM |
| Hargadon Robert Bernard | SVP, Global Human Resources | Feb 16, 2017 | Option Exercise | $40.40 | 2,327 | 94,011 | 21,346 | Feb 21, 2017, 06:16 PM |
| Guerdan Melissa | SVP, Global Quality & Reg. | Feb 16, 2017 | Option Exercise | $40.40 | 3,756 | 151,742 | 11,182 | Feb 21, 2017, 06:15 PM |
| Gladwell Mark | Senior VP, Global Operations | Feb 16, 2017 | Option Exercise | $40.40 | 3,835 | 154,934 | 7,141 | Feb 21, 2017, 06:13 PM |
| Cramp Daniella | Global Pres., Cardiometabolic | Feb 16, 2017 | Option Exercise | $40.40 | 3,734 | 150,854 | 23,885 | Feb 21, 2017, 06:09 PM |
| Chiniara Ellen | GC, Chief Ethics Officer&Sec | Feb 16, 2017 | Option Exercise | $40.40 | 3,243 | 131,017 | 28,260 | Feb 21, 2017, 06:08 PM |
| BRIDGEN JOHN | Sr VP, Business Develop | Feb 16, 2017 | Option Exercise | $40.40 | 3,145 | 127,058 | 17,525 | Feb 21, 2017, 06:05 PM |
| Wygant Jonathan | VP, Controller, CAO | Jan 15, 2017 | Option Exercise | $39.89 | 1,425 | 56,843 | 1,909 | Jan 17, 2017, 05:51 PM |
| Pelossof Avi | GlobalPres, Infectious Disease | Dec 30, 2016 | Option Exercise | $38.98 | 39,793 | 1,551,131 | 15,731 | Jan 04, 2017, 07:16 PM |
| Pelossof Avi | GlobalPres, Infectious Disease | Dec 30, 2016 | Option Exercise | $38.70 | 40,000 | 1,548,000 | 35,524 | Jan 04, 2017, 07:16 PM |
| Nawana Namal | Chief Executive Officer | Oct 31, 2016 | Option Exercise | $44.68 | 7,850 | 350,738 | 119,042 | Nov 02, 2016, 07:17 PM |
| Chiniara Ellen | GC, Chief Ethics Officer&Sec | Oct 14, 2016 | Option Exercise | $42.95 | 18,891 | 811,368 | 21,529 | Oct 18, 2016, 05:40 PM |
| Chiniara Ellen | GC, Chief Ethics Officer&Sec | Oct 14, 2016 | Option Exercise | $37.74 | 25,000 | 943,500 | 29,185 | Oct 18, 2016, 05:40 PM |
| Gladwell Mark | Senior VP, Global Operations | Oct 03, 2016 | Option Exercise | $43.24 | 1,337 | 57,812 | 2,813 | Oct 05, 2016, 05:26 PM |
| Gladwell Mark | Senior VP, Global Operations | Oct 03, 2016 | Option Exercise | $34.40 | 1,500 | 51,600 | 4,150 | Oct 05, 2016, 05:26 PM |
| Guerdan Melissa | SVP, Global Quality & Reg. | Sep 09, 2016 | Option Exercise | $42.34 | 3,131 | 132,567 | 5,202 | Sep 13, 2016, 05:24 PM |
| Gladwell Mark | Senior VP, Global Operations | Sep 09, 2016 | Option Exercise | $42.34 | 2,350 | 99,499 | 2,650 | Sep 13, 2016, 05:24 PM |
| Flakne Carla | VP, Chief Accounting Officer | Jan 16, 2015 | Sale | $42.44 | 10,000 | 424,450 | 3,714 | Apr 27, 2016, 05:21 PM |
| GOLDBERG CAROL R | Director | May 13, 2015 | Option Exercise | $49.78 | 14,076 | 700,703 | 35,084 | Apr 12, 2016, 03:08 PM |
| GOLDBERG CAROL R | Director | May 13, 2015 | Option Exercise | $28.03 | 25,000 | 700,750 | 49,160 | Apr 12, 2016, 03:08 PM |
| GOLDBERG CAROL R | Director | Jan 13, 2015 | Sale | $39.46 | 110 | 4,341 | 40,024 | Apr 12, 2016, 03:07 PM |
| Chiniara Ellen | GC, Chief Ethics Officer&Sec | Dec 31, 2015 | Option Exercise | $33.23 | 232 | 7,709 | 8,753 | Feb 18, 2016, 05:29 PM |
| Cramp Daniella | Global Pres., Cardiometabolic | Dec 31, 2015 | Option Exercise | $33.23 | 232 | 7,709 | 10,901 | Feb 18, 2016, 05:29 PM |
| Flakne Carla | VP, Chief Accounting Officer | Dec 31, 2015 | Option Exercise | $33.23 | 232 | 7,709 | 5,673 | Feb 18, 2016, 05:29 PM |
| Malkani Sanjay | Global Pres., Toxicology | Dec 31, 2015 | Option Exercise | $33.23 | 232 | 7,709 | 10,437 | Feb 18, 2016, 05:29 PM |
| Guerdan Melissa | SVP, Global Quality & Reg. | Feb 01, 2016 | Option Exercise | $33.73 | 2,500 | 84,325 | 2,500 | Feb 03, 2016, 05:24 PM |
| Guerdan Melissa | SVP, Global Quality & Reg. | Feb 01, 2016 | Sale | $54.00 | 2,500 | 135,000 | 0 | Feb 03, 2016, 05:24 PM |
| Hargadon Robert Bernard | SVP, Global Human Resources | Nov 13, 2015 | Buy | $38.99 | 1,000 | 38,990 | 8,843 | Nov 16, 2015, 09:30 AM |
| Hinrichs James F. | Executive VP, CFO | Nov 12, 2015 | Buy | $39.97 | 10,000 | 399,700 | 30,000 | Nov 12, 2015, 01:49 PM |
| Guerdan Melissa | SVP, Global Quality & Reg. | Sep 03, 2015 | Sale | $52.00 | 5,135 | 267,020 | 0 | Sep 04, 2015, 04:01 PM |
| Gladwell Mark | Senior VP, Global Operations | Sep 03, 2015 | Sale | $52.26 | 2,651 | 138,555 | 0 | Sep 04, 2015, 04:01 PM |
| Chiniara Ellen | GC, Chief Ethics Officer&Sec | Aug 31, 2015 | Option Exercise | $51.97 | 2,166 | 112,567 | 8,521 | Sep 02, 2015, 04:53 PM |
| Chiniara Ellen | GC, Chief Ethics Officer&Sec | Jun 30, 2015 | Option Exercise | $31.84 | 270 | 8,597 | 4,021 | Sep 02, 2015, 04:53 PM |
| Gladwell Mark | Senior VP, Global Operations | Aug 31, 2015 | Option Exercise | $51.97 | 2,349 | 122,078 | 2,651 | Sep 02, 2015, 04:52 PM |
| Gladwell Mark | Senior VP, Global Operations | Aug 31, 2015 | Option Exercise | $24.94 | 27,513 | 686,129 | 30,164 | Sep 02, 2015, 04:52 PM |
| Gladwell Mark | Senior VP, Global Operations | Aug 31, 2015 | Sale | $52.23 | 27,513 | 1,437,059 | 2,651 | Sep 02, 2015, 04:52 PM |
| Hargadon Robert Bernard | SVP, Global Human Resources | Aug 31, 2015 | Option Exercise | $51.97 | 1,823 | 94,741 | 7,843 | Sep 02, 2015, 04:52 PM |
| Flakne Carla | VP, Chief Accounting Officer | Aug 31, 2015 | Option Exercise | $51.97 | 1,083 | 56,284 | 5,441 | Sep 02, 2015, 04:52 PM |
| Flakne Carla | VP, Chief Accounting Officer | Jun 30, 2015 | Option Exercise | $31.84 | 243 | 7,737 | 3,191 | Sep 02, 2015, 04:52 PM |
| Pelossof Avi | GlobalPres, Infectious Disease | Aug 31, 2015 | Option Exercise | $51.97 | 2,464 | 128,054 | 8,857 | Sep 02, 2015, 04:51 PM |
| Guerdan Melissa | SVP, Global Quality & Reg. | Aug 31, 2015 | Option Exercise | $51.97 | 3,198 | 166,200 | 5,135 | Sep 02, 2015, 04:51 PM |
| Guerdan Melissa | SVP, Global Quality & Reg. | Sep 01, 2015 | Option Exercise | $18.78 | 5,000 | 93,900 | 10,135 | Sep 02, 2015, 04:51 PM |
| Guerdan Melissa | SVP, Global Quality & Reg. | Sep 01, 2015 | Sale | $50.48 | 5,000 | 252,412 | 5,135 | Sep 02, 2015, 04:51 PM |
| Cramp Daniella | Global Pres., Cardiometabolic | Aug 31, 2015 | Option Exercise | $51.97 | 2,505 | 130,185 | 10,669 | Sep 02, 2015, 04:51 PM |
| Cramp Daniella | Global Pres., Cardiometabolic | Jun 30, 2015 | Option Exercise | $31.84 | 333 | 10,603 | 6,508 | Sep 02, 2015, 04:51 PM |
| Malkani Sanjay | Global Pres., Toxicology | Aug 31, 2015 | Option Exercise | $51.97 | 3,016 | 156,742 | 10,205 | Sep 02, 2015, 04:50 PM |
| Malkani Sanjay | Global Pres., Toxicology | Jun 30, 2015 | Option Exercise | $31.84 | 333 | 10,603 | 6,555 | Sep 02, 2015, 04:50 PM |
| BRIDGEN JOHN | Sr VP, Business Develop | Aug 31, 2015 | Option Exercise | $51.97 | 2,045 | 106,279 | 7,507 | Sep 02, 2015, 04:50 PM |
| Malkani Sanjay | Global Pres., Toxicology | Aug 14, 2015 | Option Exercise | $31.35 | 31,460 | 986,324 | 37,682 | Aug 18, 2015, 04:50 PM |
| Malkani Sanjay | Global Pres., Toxicology | Aug 14, 2015 | Sale | $54.60 | 31,460 | 1,717,716 | 6,222 | Aug 18, 2015, 04:50 PM |
| Hinrichs James F. | Executive VP, CFO | Aug 07, 2015 | Buy | $49.33 | 20,000 | 986,570 | 20,000 | Aug 10, 2015, 02:16 PM |
| Malkani Sanjay | Global Pres., Toxicology | Jun 08, 2015 | Option Exercise | $19.19 | 24,331 | 466,905 | 30,553 | Jun 10, 2015, 05:03 PM |
| Malkani Sanjay | Global Pres., Toxicology | Jun 08, 2015 | Sale | $50.87 | 24,331 | 1,237,645 | 6,222 | Jun 10, 2015, 05:03 PM |
| Malkani Sanjay | Global Pres., Toxicology | Jun 04, 2015 | Option Exercise | $35.44 | 15,669 | 555,245 | 21,891 | Jun 08, 2015, 04:48 PM |
| Malkani Sanjay | Global Pres., Toxicology | Jun 04, 2015 | Sale | $52.18 | 15,669 | 817,640 | 6,222 | Jun 08, 2015, 04:48 PM |
| BRIDGEN JOHN | Sr VP, Business Develop | Jun 01, 2015 | Option Exercise | $26.06 | 7,500 | 195,450 | 12,052 | Jun 02, 2015, 05:07 PM |
| BRIDGEN JOHN | Sr VP, Business Develop | Jun 01, 2015 | Sale | $51.19 | 7,500 | 383,933 | 4,552 | Jun 02, 2015, 05:07 PM |
| BRIDGEN JOHN | Sr VP, Business Develop | May 29, 2015 | Option Exercise | $35.58 | 22,564 | 802,827 | 27,116 | Jun 02, 2015, 05:07 PM |
| BRIDGEN JOHN | Sr VP, Business Develop | May 29, 2015 | Sale | $51.17 | 22,564 | 1,154,487 | 4,552 | Jun 02, 2015, 05:07 PM |
| QUELCH JOHN | Director | May 22, 2015 | Option Exercise | $51.30 | 13,659 | 700,707 | 21,121 | May 27, 2015, 04:48 PM |
| QUELCH JOHN | Director | May 22, 2015 | Option Exercise | $28.03 | 25,000 | 700,750 | 34,780 | May 27, 2015, 04:48 PM |
| GOLDBERG CAROL R | Director | May 13, 2015 | Option Exercise | $49.78 | 14,076 | 700,703 | 10,924 | May 15, 2015, 05:07 PM |
| GOLDBERG CAROL R | Director | May 13, 2015 | Option Exercise | $28.03 | 25,000 | 700,750 | 25,000 | May 15, 2015, 05:07 PM |
| GOLDBERG CAROL R | Director | Jan 13, 2015 | Sale | $39.46 | 110 | 4,341 | 0 | May 15, 2015, 05:06 PM |
| Guerdan Melissa | SVP, Global Quality & Reg. | Apr 30, 2015 | Option Exercise | $25.68 | 3,031 | 77,836 | 3,031 | May 04, 2015, 04:58 PM |
| Guerdan Melissa | SVP, Global Quality & Reg. | Apr 30, 2015 | Sale | $47.81 | 3,031 | 144,912 | 0 | May 04, 2015, 04:58 PM |
| LEVY JOHN F | Director | Apr 20, 2015 | Option Exercise | $50.05 | 14,000 | 700,700 | 158,125 | Apr 22, 2015, 08:32 PM |
| LEVY JOHN F | Director | Apr 20, 2015 | Option Exercise | $28.03 | 25,000 | 700,750 | 172,125 | Apr 22, 2015, 08:32 PM |
| Flakne Carla | VP, Chief Accounting Officer | Mar 16, 2015 | Option Exercise | $38.79 | 8,500 | 329,730 | 11,752 | Apr 16, 2015, 09:53 AM |
| Flakne Carla | VP, Chief Accounting Officer | Mar 16, 2015 | Sale | $48.99 | 8,500 | 416,449 | 3,252 | Apr 16, 2015, 09:53 AM |
| Guerdan Melissa | SVP, Global Quality & Reg. | Apr 06, 2015 | Option Exercise | $33.73 | 2,500 | 84,325 | 2,500 | Apr 08, 2015, 07:53 PM |
| Guerdan Melissa | SVP, Global Quality & Reg. | Apr 06, 2015 | Sale | $50.00 | 2,500 | 125,000 | 0 | Apr 08, 2015, 07:53 PM |
| Guerdan Melissa | SVP, Global Quality & Reg. | Mar 23, 2015 | Option Exercise | $20.33 | 13,476 | 273,993 | 13,476 | Mar 25, 2015, 04:38 PM |
| Guerdan Melissa | SVP, Global Quality & Reg. | Mar 23, 2015 | Sale | $48.35 | 13,476 | 651,497 | 0 | Mar 25, 2015, 04:38 PM |
| BRIDGEN JOHN | Sr VP, Business Develop | Mar 17, 2015 | Option Exercise | $42.26 | 25,000 | 1,056,500 | 29,552 | Mar 19, 2015, 04:35 PM |
| BRIDGEN JOHN | Sr VP, Business Develop | Mar 17, 2015 | Sale | $48.53 | 25,000 | 1,213,250 | 4,552 | Mar 19, 2015, 04:35 PM |
| Flakne Carla | VP, Chief Accounting Officer | Mar 16, 2015 | Option Exercise | $38.79 | 8,500 | 329,730 | 8,500 | Mar 18, 2015, 06:20 PM |
| Flakne Carla | VP, Chief Accounting Officer | Mar 16, 2015 | Sale | $48.99 | 8,500 | 416,449 | 0 | Mar 18, 2015, 06:20 PM |
| Gladwell Mark | Senior VP, Global Operations | Feb 23, 2015 | Option Exercise | $28.03 | 12,500 | 350,375 | 13,292 | Feb 25, 2015, 04:54 PM |
| Gladwell Mark | Senior VP, Global Operations | Feb 23, 2015 | Sale | $44.62 | 13,292 | 593,036 | 792 | Feb 25, 2015, 04:54 PM |
| Flakne Carla | VP, Chief Accounting Officer | Jan 16, 2015 | Option Exercise | $23.15 | 10,000 | 231,500 | 13,252 | Jan 20, 2015, 04:10 PM |
| Flakne Carla | VP, Chief Accounting Officer | Jan 16, 2015 | Sale | $42.44 | 10,000 | 424,450 | 3,252 | Jan 20, 2015, 04:10 PM |
| BRIDGEN JOHN | Sr VP, Business Develop | Dec 11, 2014 | Option Exercise | $24.25 | 50,000 | 1,212,500 | 54,552 | Dec 12, 2014, 01:12 PM |
| BRIDGEN JOHN | Sr VP, Business Develop | Dec 11, 2014 | Sale | $37.07 | 50,000 | 1,853,400 | 4,552 | Dec 12, 2014, 01:12 PM |
| Teitel Dave | Chief Financial Officer | Aug 15, 2014 | Option Exercise | $24.25 | 10,000 | 242,500 | 15,002 | Aug 18, 2014, 04:09 PM |
| Teitel Dave | Chief Financial Officer | Aug 15, 2014 | Sale | $35.07 | 10,000 | 350,700 | 5,002 | Aug 18, 2014, 04:09 PM |
| Nawana Namal | Chief Operating Officer | Dec 30, 2013 | Option Exercise | $36.16 | 4,097 | 148,148 | 903 | Jan 02, 2014, 06:03 PM |
| SCOTT DAVID | Chief Scientific Officer | Dec 16, 2013 | Option Exercise | $35.31 | 3,682 | 130,011 | 477,239 | Dec 18, 2013, 04:20 PM |
| SCOTT DAVID | Chief Scientific Officer | Dec 16, 2013 | Option Exercise | $21.78 | 5,252 | 114,389 | 480,921 | Dec 18, 2013, 04:20 PM |
| MCALEER JEROME F | Sr. VP, Research & Development | Dec 12, 2013 | Option Exercise | $33.81 | 3,312 | 111,979 | 300,419 | Dec 16, 2013, 04:15 PM |
| MCALEER JEROME F | Sr. VP, Research & Development | Dec 12, 2013 | Option Exercise | $21.78 | 4,656 | 101,408 | 303,731 | Dec 16, 2013, 04:15 PM |
| BRIDGEN JOHN | Sr VP, Business Develop | Dec 12, 2013 | Option Exercise | $33.81 | 4,745 | 160,428 | 4,552 | Dec 16, 2013, 04:14 PM |
| BRIDGEN JOHN | Sr VP, Business Develop | Dec 12, 2013 | Option Exercise | $21.78 | 6,664 | 145,142 | 9,297 | Dec 16, 2013, 04:14 PM |
| Torchilin Kate | VP, Connected Health | Dec 11, 2013 | Option Exercise | $26.02 | 10,675 | 277,765 | 10,000 | Dec 13, 2013, 04:55 PM |
| Torchilin Kate | VP, Connected Health | Dec 11, 2013 | Sale | $33.73 | 8,547 | 288,265 | 2,128 | Dec 13, 2013, 04:55 PM |
| HEMPEL PAUL T | SVP Ethics & Compliance | Nov 13, 2013 | Option Exercise | $21.78 | 921 | 20,059 | 20,783 | Nov 14, 2013, 09:37 PM |
| HEMPEL PAUL T | SVP Ethics & Compliance | Nov 12, 2013 | Option Exercise | $21.78 | 3,655 | 79,606 | 23,517 | Nov 14, 2013, 09:37 PM |
| HEMPEL PAUL T | SVP Ethics & Compliance | Nov 13, 2013 | Sale | $33.68 | 921 | 31,016 | 19,862 | Nov 14, 2013, 09:37 PM |
| HEMPEL PAUL T | SVP Ethics & Compliance | Nov 12, 2013 | Sale | $33.75 | 3,655 | 123,356 | 19,862 | Nov 14, 2013, 09:37 PM |
| ZWANZIGER RON | Chairman, CEO & President | Nov 01, 2013 | Option Exercise | $21.78 | 7,576 | 165,005 | 12,061 | Nov 05, 2013, 09:23 PM |
| Teitel Dave | Chief Financial Officer | Aug 15, 2013 | Option Exercise | $21.38 | 10,000 | 213,800 | 14,506 | Aug 16, 2013, 05:36 PM |
| Teitel Dave | Chief Financial Officer | Aug 15, 2013 | Sale | $31.73 | 10,000 | 317,282 | 4,506 | Aug 16, 2013, 05:36 PM |
| Cotton Michael Lester | Global Pres, Health Mgmt | Aug 05, 2013 | Option Exercise | $29.55 | 12,500 | 369,375 | 12,500 | Aug 07, 2013, 06:49 PM |
| Cotton Michael Lester | Global Pres, Health Mgmt | Aug 05, 2013 | Sale | $33.82 | 12,500 | 422,750 | 0 | Aug 07, 2013, 06:49 PM |
| Cotton Michael Lester | Global Pres, Health Mgmt | May 31, 2013 | Option Exercise | $25.43 | 8,750 | 222,513 | 8,750 | Jun 04, 2013, 02:37 PM |
| Cotton Michael Lester | Global Pres, Health Mgmt | May 31, 2013 | Sale | $25.86 | 8,750 | 226,240 | 0 | Jun 04, 2013, 02:37 PM |
| Post Jim | President, Acute Care | Mar 07, 2013 | Sale | $23.37 | 1,075 | 25,123 | 0 | Mar 11, 2013, 08:19 PM |
| QUELCH JOHN | Director | Mar 05, 2013 | Option Exercise | $16.20 | 25,000 | 405,000 | 30,000 | Mar 07, 2013, 12:06 PM |
| QUELCH JOHN | Director | Mar 05, 2013 | Sale | $23.49 | 20,220 | 475,065 | 9,780 | Mar 07, 2013, 12:06 PM |
| EYLENBOSCH HILDE | President, Alere International | Mar 01, 2013 | Option Exercise | $16.20 | 2,500 | 40,500 | 32,636 | Mar 05, 2013, 10:03 AM |
| EYLENBOSCH HILDE | President, Alere International | Mar 01, 2013 | Sale | $22.69 | 2,391 | 54,245 | 30,245 | Mar 05, 2013, 10:03 AM |
| Post Jim | President, Alere NA | Aug 23, 2012 | Sale | $18.77 | 840 | 15,767 | 502 | Aug 27, 2012, 04:24 PM |
| TOOHEY DAVID | President, Intl Bus. Operation | Aug 14, 2012 | Option Exercise | $15.55 | 151 | 2,348 | 9,238 | Aug 16, 2012, 03:30 PM |
| TOOHEY DAVID | President, Intl Bus. Operation | Aug 14, 2012 | Sale | $18.28 | 151 | 2,760 | 9,087 | Aug 16, 2012, 03:30 PM |
| BRIDGEN JOHN | Sr VP, Business Develop | Aug 07, 2012 | Option Exercise | $11.75 | 11,721 | 137,722 | 14,354 | Aug 09, 2012, 04:50 PM |
| BRIDGEN JOHN | Sr VP, Business Develop | Aug 07, 2012 | Sale | $18.96 | 11,721 | 222,218 | 2,633 | Aug 09, 2012, 04:50 PM |
| LEVY JOHN F | Director | Aug 02, 2012 | Option Exercise | $13.54 | 4,000 | 54,160 | 147,125 | Aug 03, 2012, 03:03 PM |
| BRIDGEN JOHN | VP, Strategic Business Develop | Jul 19, 2012 | Option Exercise | $11.75 | 4,752 | 55,836 | 7,385 | Jul 23, 2012, 03:25 PM |
| BRIDGEN JOHN | VP, Strategic Business Develop | Jul 19, 2012 | Sale | $20.00 | 4,752 | 95,040 | 2,633 | Jul 23, 2012, 03:25 PM |
| ZWANZIGER RON | Chairman, CEO & President | Jun 14, 2012 | Option Exercise | $15.55 | 5,065 | 78,761 | 9,550 | Jun 18, 2012, 04:20 PM |
| HEMPEL PAUL T | SVP Ethics & Compliance | Jun 13, 2012 | Option Exercise | $16.65 | 10,913 | 181,697 | 28,598 | Jun 15, 2012, 03:28 PM |
| HEMPEL PAUL T | SVP Ethics & Compliance | Jun 13, 2012 | Sale | $19.01 | 10,113 | 192,201 | 28,398 | Jun 15, 2012, 03:28 PM |
| Hart Emanuel | President, LAmARCIS | Jun 05, 2012 | Option Exercise | $15.55 | 2,316 | 36,014 | 13,308 | Jun 07, 2012, 03:03 PM |
| MCALEER JEROME F | VP, Research & Development | May 29, 2012 | Option Exercise | $15.60 | 1,805 | 28,158 | 299,075 | May 31, 2012, 03:31 PM |
| BRIDGEN JOHN | VP, Strategic Business Develop | Apr 26, 2012 | Option Exercise | $11.75 | 3,486 | 40,961 | 6,119 | Apr 30, 2012, 03:19 PM |
| BRIDGEN JOHN | VP, Strategic Business Develop | Apr 26, 2010 | Sale | $25.00 | 3,486 | 87,150 | 2,633 | Apr 30, 2012, 03:19 PM |
| BRIDGEN JOHN | VP, Strategic Business Develop | Mar 07, 2012 | Option Exercise | $11.75 | 4,357 | 51,195 | 6,990 | Mar 09, 2012, 11:45 AM |
| BRIDGEN JOHN | VP, Strategic Business Develop | Mar 07, 2012 | Sale | $25.00 | 4,357 | 108,925 | 2,633 | Mar 09, 2012, 11:45 AM |
| Underwood Thomas | CEO, Alere Health LLC | Feb 16, 2012 | Option Exercise | $18.91 | 750 | 14,182 | 2,250 | Feb 21, 2012, 04:56 PM |
| Underwood Thomas | CEO, Alere Health LLC | Feb 16, 2012 | Sale | $26.02 | 750 | 19,516 | 1,500 | Feb 21, 2012, 04:56 PM |
| BRIDGEN JOHN | VP, Strategic Business Develop | Feb 07, 2012 | Option Exercise | $11.75 | 5,446 | 63,991 | 8,079 | Feb 09, 2012, 03:02 PM |
| BRIDGEN JOHN | VP, Strategic Business Develop | Feb 07, 2012 | Sale | $25.10 | 5,446 | 136,695 | 2,633 | Feb 09, 2012, 03:02 PM |
| BRIDGEN JOHN | VP, Strategic Business Develop | Feb 02, 2012 | Option Exercise | $11.75 | 6,808 | 79,994 | 9,441 | Feb 06, 2012, 04:36 PM |
| BRIDGEN JOHN | VP, Strategic Business Develop | Feb 02, 2012 | Sale | $25.00 | 6,808 | 170,200 | 2,633 | Feb 06, 2012, 04:36 PM |
| SCOTT DAVID | Chief Technical Officer | Nov 16, 2011 | Option Exercise | $15.47 | 199,691 | 3,089,220 | 639,906 | Dec 01, 2011, 07:10 PM |
| SCOTT DAVID | Chief Technical Officer | Nov 16, 2011 | Sale | $26.02 | 164,237 | 4,273,775 | 475,669 | Dec 01, 2011, 07:10 PM |
| MCALEER JEROME F | VP, Research & Development | Nov 28, 2011 | Option Exercise | $16.76 | 129,413 | 2,168,962 | 414,099 | Nov 30, 2011, 08:02 PM |
| MCALEER JEROME F | VP, Research & Development | Nov 28, 2011 | Sale | $22.25 | 116,829 | 2,599,211 | 297,270 | Nov 30, 2011, 08:02 PM |
| MCALEER JEROME F | VP, Research & Development | Nov 22, 2011 | Option Exercise | $19.02 | 351,840 | 6,690,862 | 446,820 | Nov 25, 2011, 08:58 AM |
| ZWANZIGER RON | Chairman, CEO & President | Nov 21, 2011 | Option Exercise | $16.97 | 36,794 | 624,571 | 1,806,696 | Nov 22, 2011, 04:16 PM |
| ZWANZIGER RON | Chairman, CEO & President | Nov 21, 2011 | Option Exercise | $17.15 | 65,000 | 1,114,750 | 525,859 | Nov 22, 2011, 04:16 PM |
| SCOTT DAVID | Chief Technical Officer | Nov 16, 2011 | Option Exercise | $14.57 | 199,691 | 2,909,498 | 639,906 | Nov 18, 2011, 04:23 PM |
| SCOTT DAVID | Chief Technical Officer | Nov 16, 2011 | Sale | $26.02 | 164,237 | 4,273,775 | 475,669 | Nov 18, 2011, 04:23 PM |
| EYLENBOSCH HILDE | Chief Commercial Officer | Nov 15, 2011 | Option Exercise | $15.47 | 17,229 | 266,533 | 47,365 | Nov 17, 2011, 04:29 PM |
| EYLENBOSCH HILDE | Chief Commercial Officer | Nov 15, 2011 | Sale | $26.02 | 17,229 | 448,367 | 30,136 | Nov 17, 2011, 04:29 PM |
| LEVY JOHN F | Director | Nov 01, 2011 | Option Exercise | $18.73 | 25,000 | 468,250 | 143,125 | Nov 02, 2011, 08:48 PM |
| Roosevelt James Jr. | Director | Aug 23, 2011 | Buy | $22.50 | 4,444 | 99,990 | 4,444 | Aug 24, 2011, 09:08 PM |
| Underwood Thomas | CEO, Alere Health LLC | Aug 11, 2011 | Buy | $23.44 | 1,500 | 35,160 | 1,500 | Aug 12, 2011, 09:09 AM |
| Hargadon Robert Bernard | VP, Global Culture & Performan | Aug 09, 2011 | Buy | $22.92 | 2,000 | 45,841 | 3,000 | Aug 10, 2011, 04:25 PM |
| EYLENBOSCH HILDE | Chief Commercial Officer | Jul 29, 2011 | Option Exercise | $15.47 | 22,771 | 352,267 | 30,136 | Aug 01, 2011, 01:19 PM |
| GOLDBERG CAROL R | Director | Apr 21, 2011 | Option Exercise | $18.73 | 11,650 | 218,204 | 47,530 | Apr 25, 2011, 09:07 PM |
| HEMPEL PAUL T | SVP Ethics & Compliance | Mar 15, 2011 | Option Exercise | $15.47 | 25,856 | 399,992 | 36,259 | Mar 17, 2011, 07:45 PM |
| HEMPEL PAUL T | SVP Ethics & Compliance | Mar 15, 2011 | Sale | $36.75 | 19,209 | 705,968 | 30,084 | Mar 17, 2011, 07:45 PM |
| EYLENBOSCH HILDE | Chief Commercial Officer | Feb 25, 2011 | Option Exercise | $15.91 | 4,565 | 72,611 | 7,365 | Mar 01, 2011, 09:34 PM |
| EYLENBOSCH HILDE | Chief Commercial Officer | Jan 19, 2011 | Option Exercise | $14.92 | 1,200 | 17,904 | 2,800 | Mar 01, 2011, 09:25 PM |
| ZWANZIGER RON | Chairman, CEO & President | Feb 08, 2011 | Option Exercise | $24.08 | 47,500 | 1,143,663 | 561,298 | Feb 10, 2011, 04:39 PM |
| MCALEER JEROME F | VP, Research & Development | Jan 27, 2011 | Option Exercise | $27.46 | 32,000 | 878,720 | 273,114 | Jan 31, 2011, 02:52 PM |
| SCOTT DAVID | Chief Technical Officer | Jan 27, 2011 | Option Exercise | $25.27 | 40,851 | 1,032,120 | 457,006 | Jan 31, 2011, 02:52 PM |
| EYLENBOSCH HILDE | Chief Commercial Officer | Jan 26, 2011 | Option Exercise | $14.92 | 4,000 | 59,680 | 33,303 | Jan 28, 2011, 03:55 PM |
| EYLENBOSCH HILDE | Chief Commercial Officer | Jan 19, 2011 | Option Exercise | $14.92 | 1,200 | 17,904 | 4,448 | Jan 21, 2011, 02:44 PM |
| HEMPEL PAUL T | Sr VP, LD & Legal Affairs | Nov 12, 2010 | Option Exercise | $14.58 | 2,000 | 29,160 | 11,004 | Nov 16, 2010, 05:08 PM |
| HEMPEL PAUL T | Sr VP, LD & Legal Affairs | Nov 12, 2010 | Sale | $29.22 | 1,020 | 29,804 | 9,984 | Nov 16, 2010, 05:08 PM |
| Adashi Eli | Director | Aug 27, 2010 | Buy | $28.80 | 850 | 24,480 | 850 | Aug 31, 2010, 07:06 PM |
| QUELCH JOHN | Director | Jul 30, 2010 | Buy | $28.35 | 5,000 | 141,735 | 5,000 | Aug 03, 2010, 04:34 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Cramp Daniella | Global Pres., Cardiometabolic | 08/31/2017 | 606,083 |
| Cramp Daniella | Global Pres., Cardiometabolic | 08/31/2017 | 481,400 |
| BRIDGEN JOHN | Sr VP, Business Develop | 08/31/2017 | 92,935 |
| Chiniara Ellen | GC, Chief Ethics Officer&Sec | 08/31/2017 | 106,982 |
| Gladwell Mark | Senior VP, Global Operations | 08/31/2017 | 116,231 |
| Guerdan Melissa | SVP, Global Quality & Reg. | 08/31/2017 | 154,859 |
| Hargadon Robert Bernard | SVP, Global Human Resources | 08/31/2017 | 90,166 |
| Malkani Sanjay | Global Pres., Toxicology | 08/31/2017 | 100,799 |
| Pelossof Avi | GlobalPres, Infectious Disease | 08/31/2017 | 121,869 |
| Nawana Namal | Chief Executive Officer | 01/15/2017 | 938,412 |
| Uppaluri Renuka | Senior VP, Global R&D | 02/28/2017 | 95,941 |
| Uppaluri Renuka | Senior VP, Global R&D | 02/16/2017 | 128,028 |
| Pelossof Avi | GlobalPres, Infectious Disease | 02/16/2017 | 148,066 |
| Nawana Namal | Chief Executive Officer | 02/16/2017 | 750,470 |
| Malkani Sanjay | Global Pres., Toxicology | 02/16/2017 | 122,291 |
| Hinrichs James F. | Executive VP, CFO | 02/16/2017 | 212,504 |
| Hargadon Robert Bernard | SVP, Global Human Resources | 02/16/2017 | 94,011 |
| Guerdan Melissa | SVP, Global Quality & Reg. | 02/16/2017 | 151,742 |
| Gladwell Mark | Senior VP, Global Operations | 02/16/2017 | 154,934 |
| Cramp Daniella | Global Pres., Cardiometabolic | 02/16/2017 | 150,854 |
| Chiniara Ellen | GC, Chief Ethics Officer&Sec | 02/16/2017 | 131,017 |
| BRIDGEN JOHN | Sr VP, Business Develop | 02/16/2017 | 127,058 |
| Wygant Jonathan | VP, Controller, CAO | 01/15/2017 | 56,843 |
| Pelossof Avi | GlobalPres, Infectious Disease | 12/30/2016 | 1,551,131 |
| Pelossof Avi | GlobalPres, Infectious Disease | 12/30/2016 | 1,548,000 |
| Nawana Namal | Chief Executive Officer | 10/31/2016 | 350,738 |
| Chiniara Ellen | GC, Chief Ethics Officer&Sec | 10/14/2016 | 811,368 |
| Chiniara Ellen | GC, Chief Ethics Officer&Sec | 10/14/2016 | 943,500 |
| Gladwell Mark | Senior VP, Global Operations | 10/03/2016 | 57,812 |
| Gladwell Mark | Senior VP, Global Operations | 10/03/2016 | 51,600 |
| Guerdan Melissa | SVP, Global Quality & Reg. | 09/09/2016 | 132,567 |
| Gladwell Mark | Senior VP, Global Operations | 09/09/2016 | 99,499 |
| Flakne Carla | VP, Chief Accounting Officer | 01/16/2015 | 424,450 |
| GOLDBERG CAROL R | Director | 05/13/2015 | 700,703 |
| GOLDBERG CAROL R | Director | 05/13/2015 | 700,750 |
| GOLDBERG CAROL R | Director | 01/13/2015 | 4,341 |
| Chiniara Ellen | GC, Chief Ethics Officer&Sec | 12/31/2015 | 7,709 |
| Cramp Daniella | Global Pres., Cardiometabolic | 12/31/2015 | 7,709 |
| Flakne Carla | VP, Chief Accounting Officer | 12/31/2015 | 7,709 |
| Malkani Sanjay | Global Pres., Toxicology | 12/31/2015 | 7,709 |
| Guerdan Melissa | SVP, Global Quality & Reg. | 02/01/2016 | 84,325 |
| Guerdan Melissa | SVP, Global Quality & Reg. | 02/01/2016 | 135,000 |
| Hargadon Robert Bernard | SVP, Global Human Resources | 11/13/2015 | 38,990 |
| Hinrichs James F. | Executive VP, CFO | 11/12/2015 | 399,700 |
| Guerdan Melissa | SVP, Global Quality & Reg. | 09/03/2015 | 267,020 |
| Gladwell Mark | Senior VP, Global Operations | 09/03/2015 | 138,555 |
| Chiniara Ellen | GC, Chief Ethics Officer&Sec | 08/31/2015 | 112,567 |
| Chiniara Ellen | GC, Chief Ethics Officer&Sec | 06/30/2015 | 8,597 |
| Gladwell Mark | Senior VP, Global Operations | 08/31/2015 | 122,078 |
| Gladwell Mark | Senior VP, Global Operations | 08/31/2015 | 686,129 |
| Gladwell Mark | Senior VP, Global Operations | 08/31/2015 | 1,437,059 |
| Hargadon Robert Bernard | SVP, Global Human Resources | 08/31/2015 | 94,741 |
| Flakne Carla | VP, Chief Accounting Officer | 08/31/2015 | 56,284 |
| Flakne Carla | VP, Chief Accounting Officer | 06/30/2015 | 7,737 |
| Pelossof Avi | GlobalPres, Infectious Disease | 08/31/2015 | 128,054 |
| Guerdan Melissa | SVP, Global Quality & Reg. | 08/31/2015 | 166,200 |
| Guerdan Melissa | SVP, Global Quality & Reg. | 09/01/2015 | 93,900 |
| Guerdan Melissa | SVP, Global Quality & Reg. | 09/01/2015 | 252,412 |
| Cramp Daniella | Global Pres., Cardiometabolic | 08/31/2015 | 130,185 |
| Cramp Daniella | Global Pres., Cardiometabolic | 06/30/2015 | 10,603 |
| Malkani Sanjay | Global Pres., Toxicology | 08/31/2015 | 156,742 |
| Malkani Sanjay | Global Pres., Toxicology | 06/30/2015 | 10,603 |
| BRIDGEN JOHN | Sr VP, Business Develop | 08/31/2015 | 106,279 |
| Malkani Sanjay | Global Pres., Toxicology | 08/14/2015 | 986,324 |
| Malkani Sanjay | Global Pres., Toxicology | 08/14/2015 | 1,717,716 |
| Hinrichs James F. | Executive VP, CFO | 08/07/2015 | 986,570 |
| Malkani Sanjay | Global Pres., Toxicology | 06/08/2015 | 466,905 |
| Malkani Sanjay | Global Pres., Toxicology | 06/08/2015 | 1,237,645 |
| Malkani Sanjay | Global Pres., Toxicology | 06/04/2015 | 555,245 |
| Malkani Sanjay | Global Pres., Toxicology | 06/04/2015 | 817,640 |
| BRIDGEN JOHN | Sr VP, Business Develop | 06/01/2015 | 195,450 |
| BRIDGEN JOHN | Sr VP, Business Develop | 06/01/2015 | 383,933 |
| BRIDGEN JOHN | Sr VP, Business Develop | 05/29/2015 | 802,827 |
| BRIDGEN JOHN | Sr VP, Business Develop | 05/29/2015 | 1,154,487 |
| QUELCH JOHN | Director | 05/22/2015 | 700,707 |
| QUELCH JOHN | Director | 05/22/2015 | 700,750 |
| GOLDBERG CAROL R | Director | 05/13/2015 | 700,703 |
| GOLDBERG CAROL R | Director | 05/13/2015 | 700,750 |
| GOLDBERG CAROL R | Director | 01/13/2015 | 4,341 |
| Guerdan Melissa | SVP, Global Quality & Reg. | 04/30/2015 | 77,836 |
| Guerdan Melissa | SVP, Global Quality & Reg. | 04/30/2015 | 144,912 |
| LEVY JOHN F | Director | 04/20/2015 | 700,700 |
| LEVY JOHN F | Director | 04/20/2015 | 700,750 |
| Flakne Carla | VP, Chief Accounting Officer | 03/16/2015 | 329,730 |
| Flakne Carla | VP, Chief Accounting Officer | 03/16/2015 | 416,449 |
| Guerdan Melissa | SVP, Global Quality & Reg. | 04/06/2015 | 84,325 |
| Guerdan Melissa | SVP, Global Quality & Reg. | 04/06/2015 | 125,000 |
| Guerdan Melissa | SVP, Global Quality & Reg. | 03/23/2015 | 273,993 |
| Guerdan Melissa | SVP, Global Quality & Reg. | 03/23/2015 | 651,497 |
| BRIDGEN JOHN | Sr VP, Business Develop | 03/17/2015 | 1,056,500 |
| BRIDGEN JOHN | Sr VP, Business Develop | 03/17/2015 | 1,213,250 |
| Flakne Carla | VP, Chief Accounting Officer | 03/16/2015 | 329,730 |
| Flakne Carla | VP, Chief Accounting Officer | 03/16/2015 | 416,449 |
| Gladwell Mark | Senior VP, Global Operations | 02/23/2015 | 350,375 |
| Gladwell Mark | Senior VP, Global Operations | 02/23/2015 | 593,036 |
| Flakne Carla | VP, Chief Accounting Officer | 01/16/2015 | 231,500 |
| Flakne Carla | VP, Chief Accounting Officer | 01/16/2015 | 424,450 |
| BRIDGEN JOHN | Sr VP, Business Develop | 12/11/2014 | 1,212,500 |
| BRIDGEN JOHN | Sr VP, Business Develop | 12/11/2014 | 1,853,400 |
| Teitel Dave | Chief Financial Officer | 08/15/2014 | 242,500 |
| Teitel Dave | Chief Financial Officer | 08/15/2014 | 350,700 |
| Nawana Namal | Chief Operating Officer | 12/30/2013 | 148,148 |
| SCOTT DAVID | Chief Scientific Officer | 12/16/2013 | 130,011 |
| SCOTT DAVID | Chief Scientific Officer | 12/16/2013 | 114,389 |
| MCALEER JEROME F | Sr. VP, Research & Development | 12/12/2013 | 111,979 |
| MCALEER JEROME F | Sr. VP, Research & Development | 12/12/2013 | 101,408 |
| BRIDGEN JOHN | Sr VP, Business Develop | 12/12/2013 | 160,428 |
| BRIDGEN JOHN | Sr VP, Business Develop | 12/12/2013 | 145,142 |
| Torchilin Kate | VP, Connected Health | 12/11/2013 | 277,765 |
| Torchilin Kate | VP, Connected Health | 12/11/2013 | 288,265 |
| HEMPEL PAUL T | SVP Ethics & Compliance | 11/13/2013 | 20,059 |
| HEMPEL PAUL T | SVP Ethics & Compliance | 11/12/2013 | 79,606 |
| HEMPEL PAUL T | SVP Ethics & Compliance | 11/13/2013 | 31,016 |
| HEMPEL PAUL T | SVP Ethics & Compliance | 11/12/2013 | 123,356 |
| ZWANZIGER RON | Chairman, CEO & President | 11/01/2013 | 165,005 |
| Teitel Dave | Chief Financial Officer | 08/15/2013 | 213,800 |
| Teitel Dave | Chief Financial Officer | 08/15/2013 | 317,282 |
| Cotton Michael Lester | Global Pres, Health Mgmt | 08/05/2013 | 369,375 |
| Cotton Michael Lester | Global Pres, Health Mgmt | 08/05/2013 | 422,750 |
| Cotton Michael Lester | Global Pres, Health Mgmt | 05/31/2013 | 222,513 |
| Cotton Michael Lester | Global Pres, Health Mgmt | 05/31/2013 | 226,240 |
| Post Jim | President, Acute Care | 03/07/2013 | 25,123 |
| QUELCH JOHN | Director | 03/05/2013 | 405,000 |
| QUELCH JOHN | Director | 03/05/2013 | 475,065 |
| EYLENBOSCH HILDE | President, Alere International | 03/01/2013 | 40,500 |
| EYLENBOSCH HILDE | President, Alere International | 03/01/2013 | 54,245 |
| Post Jim | President, Alere NA | 08/23/2012 | 15,767 |
| TOOHEY DAVID | President, Intl Bus. Operation | 08/14/2012 | 2,348 |
| TOOHEY DAVID | President, Intl Bus. Operation | 08/14/2012 | 2,760 |
| BRIDGEN JOHN | Sr VP, Business Develop | 08/07/2012 | 137,722 |
| BRIDGEN JOHN | Sr VP, Business Develop | 08/07/2012 | 222,218 |
| LEVY JOHN F | Director | 08/02/2012 | 54,160 |
| BRIDGEN JOHN | VP, Strategic Business Develop | 07/19/2012 | 55,836 |
| BRIDGEN JOHN | VP, Strategic Business Develop | 07/19/2012 | 95,040 |
| ZWANZIGER RON | Chairman, CEO & President | 06/14/2012 | 78,761 |
| HEMPEL PAUL T | SVP Ethics & Compliance | 06/13/2012 | 181,697 |
| HEMPEL PAUL T | SVP Ethics & Compliance | 06/13/2012 | 192,201 |
| Hart Emanuel | President, LAmARCIS | 06/05/2012 | 36,014 |
| MCALEER JEROME F | VP, Research & Development | 05/29/2012 | 28,158 |
| BRIDGEN JOHN | VP, Strategic Business Develop | 04/26/2012 | 40,961 |
| BRIDGEN JOHN | VP, Strategic Business Develop | 04/26/2010 | 87,150 |
| BRIDGEN JOHN | VP, Strategic Business Develop | 03/07/2012 | 51,195 |
| BRIDGEN JOHN | VP, Strategic Business Develop | 03/07/2012 | 108,925 |
| Underwood Thomas | CEO, Alere Health LLC | 02/16/2012 | 14,182 |
| Underwood Thomas | CEO, Alere Health LLC | 02/16/2012 | 19,516 |
| BRIDGEN JOHN | VP, Strategic Business Develop | 02/07/2012 | 63,991 |
| BRIDGEN JOHN | VP, Strategic Business Develop | 02/07/2012 | 136,695 |
| BRIDGEN JOHN | VP, Strategic Business Develop | 02/02/2012 | 79,994 |
| BRIDGEN JOHN | VP, Strategic Business Develop | 02/02/2012 | 170,200 |
| SCOTT DAVID | Chief Technical Officer | 11/16/2011 | 3,089,220 |
| SCOTT DAVID | Chief Technical Officer | 11/16/2011 | 4,273,775 |
| MCALEER JEROME F | VP, Research & Development | 11/28/2011 | 2,168,962 |
| MCALEER JEROME F | VP, Research & Development | 11/28/2011 | 2,599,211 |
| MCALEER JEROME F | VP, Research & Development | 11/22/2011 | 6,690,862 |
| ZWANZIGER RON | Chairman, CEO & President | 11/21/2011 | 624,571 |
| ZWANZIGER RON | Chairman, CEO & President | 11/21/2011 | 1,114,750 |
| SCOTT DAVID | Chief Technical Officer | 11/16/2011 | 2,909,498 |
| SCOTT DAVID | Chief Technical Officer | 11/16/2011 | 4,273,775 |
| EYLENBOSCH HILDE | Chief Commercial Officer | 11/15/2011 | 266,533 |
| EYLENBOSCH HILDE | Chief Commercial Officer | 11/15/2011 | 448,367 |
| LEVY JOHN F | Director | 11/01/2011 | 468,250 |
| Roosevelt James Jr. | Director | 08/23/2011 | 99,990 |
| Underwood Thomas | CEO, Alere Health LLC | 08/11/2011 | 35,160 |
| Hargadon Robert Bernard | VP, Global Culture & Performan | 08/09/2011 | 45,841 |
| EYLENBOSCH HILDE | Chief Commercial Officer | 07/29/2011 | 352,267 |
| GOLDBERG CAROL R | Director | 04/21/2011 | 218,204 |
| HEMPEL PAUL T | SVP Ethics & Compliance | 03/15/2011 | 399,992 |
| HEMPEL PAUL T | SVP Ethics & Compliance | 03/15/2011 | 705,968 |
| EYLENBOSCH HILDE | Chief Commercial Officer | 02/25/2011 | 72,611 |
| EYLENBOSCH HILDE | Chief Commercial Officer | 01/19/2011 | 17,904 |
| ZWANZIGER RON | Chairman, CEO & President | 02/08/2011 | 1,143,663 |
| MCALEER JEROME F | VP, Research & Development | 01/27/2011 | 878,720 |
| SCOTT DAVID | Chief Technical Officer | 01/27/2011 | 1,032,120 |
| EYLENBOSCH HILDE | Chief Commercial Officer | 01/26/2011 | 59,680 |
| EYLENBOSCH HILDE | Chief Commercial Officer | 01/19/2011 | 17,904 |
| HEMPEL PAUL T | Sr VP, LD & Legal Affairs | 11/12/2010 | 29,160 |
| HEMPEL PAUL T | Sr VP, LD & Legal Affairs | 11/12/2010 | 29,804 |
| Adashi Eli | Director | 08/27/2010 | 24,480 |
| QUELCH JOHN | Director | 07/30/2010 | 141,735 |
Load More Insider Transactions